Karyopharm Therapeutics Inc.
KPTI
Revenue
42.79M
▲9.66M▲29.16%
3 Months ChangeAssets
213.98M
▲9.52M▲4.66%
3 Months ChangeLiabilities
346.12M
▼-27.30M▼-7.31%
3 Months ChangeFree Cash Flow
-43.92M
▼-25.01M▼-132.26%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001193125-24-248162
2024-09-17
Form 8-K
ID: 0001193125-24-220534
2024-08-29
Form 8-K
ID: 0001193125-24-209907
2024-08-06
Form 10-Q
ID: 0000950170-24-091210
2024-08-06
Form 8-K
ID: 0001193125-24-194427
2024-05-31
Form 8-K
ID: 0001193125-24-151049
2024-05-14
Form 8-K
ID: 0001193125-24-138211
2024-05-08
Form 10-Q
ID: 0000950170-24-055672
2024-05-08
Form 8-K
ID: 0001193125-24-133791
2024-05-08
Form 8-K
ID: 0001193125-24-133784